North America Metabolomics Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service Type (Targeted Metabolomics Service and Untargeted Metabolomics Service) and Application (Pharmaceutical and Biotechnology Industry, Agritech, and Environment)
Market Introduction
The North America metabolomics services market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America metabolomics services market in 2021. Increasing adoption of technological advancements and rising research and development activities are projected to accelerate the growth of the metabolomics services market. Moreover, the presence of large healthcare businesses and the growing usage of metabolomics services is propelling the market's expansion in this region. In North America, the US holds the significant share of the metabolomics services market. The growth of the market in the country is primarily driven by increasing prevalence of chronic diseases such as cancer. For instance, according to the National Cancer Institute, the country will see 1,735,350 new cancer cases in 2020. Breast cancer, lung and bronchus bronchial cancer, prostate cancer, colon and rectal cancer, melanoma cancer, and liver cancer are the most common types of cancer. Cancer incidences are increasing at an alarming rate in the country, resulting in an increase in demand for cancer diagnosis. Besides, the increasing investments and rising funds dedicated to the pharma manufacturing companies as well as academic and research institutes for the development of various medicines, growing geriatric population, infectious disease, and other therapeutics is one of the major driving factors. Rising incidences of cancer is the major factor driving the growth of the North America metabolomics services market.
In North America, countries such as the US has reported the highest numbers of COVID-19 cases. The pandemic has led to chaotic situation in the healthcare sectors, with excessively increased demand for diagnosing and therapeutic devices in the hospitals. For instance, demand for ventilators, respirators, and in vitro diagnostic (IVD) tests has risen drastically in across North American countries. The demand for personal protective kits has also gone up significantly. The FDA has increased its efforts to support the health of people and has rolled out several guidelines for hospitals and healthcare companies. Companies have also enhanced their research and development activities for diagnostics tests and therapeutic devices. For instance, Thermo Fisher Scientific, F. Hoffmann-La Roche AG, EverlyWell, and Abbott, among others, are ate the forefront of COVID-19 diagnosis kit production. Thermo Fisher Scientific has increased its production to be able to produce 5 million tests per week in April. Likewise, Abbott has received Emergency Use Authorization (EUA) for a point-of-care test that can provide results in minutes.
Get more information on this report : 
Market Overview and Dynamics
The metabolomics services market in North America is expected to grow from US$ 178.89 million in 2021 to US$ 685.85 million by 2028; it is estimated to grow at a CAGR of 21.2% from 2021 to 2028. The economies across the region are creating significant opportunities for the key market players to expand their businesses. The majority of players concentrate on big countries, owing to the large population suffering from chronic diseases in these countries. With rising production costs against their practices, the healthcare companies are striving to produce sufficient revenue to entertain their investors. The markets in a few growing economies are expected to be an essential part of offering more reliable and profitable growth opportunities for the major players to expand their industry. Advancements in biotechnology have increased the demand for diagnostics in the healthcare market, encouraging the introduction of more analytical systems and facilitating the shift toward personalized medicine. There are new opportunities in infectious disease testing, molecular oncology, and pharmacogenomics in emerging countries. Hence, healthcare companies can target patients or consumers in several nations. Various players in the industry have been investing a significant amount of their revenue in R&D activities to develop better and advanced products and technologies to be used in the healthcare industry. Thus, the rising number of diseases such as cancer and advancements in several countries are likely to boost the market and are anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.
Key Market Segments
The North America metabolomics services market has been segmented based on service type, application, and country. On the basis of service type, the North America metabolomics services market is segmented into targeted metabolomics service and untargeted metabolomics service. The targeted metabolomics service segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Based on application, the market is segmented into pharmaceutical and biotechnology industry, agritech, and environment. The pharmaceutical and biotechnology industry segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. Likewise, the pharmaceutical and biotechnology industry segmented is categorized into biomarker discovery, drug discovery, toxicological testing, and others.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on metabolomics services market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; BGI; biocrates life sciences ag; Chenomx Inc.; Creative Proteomics; Fred Hutchinson Cancer Research Center; Metabolon, Inc.; Molecular You; RTI International; TMIC; and West Coast Metabolomics Center are among others.
Reasons to buy report
- To understand the North America metabolomics services market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America metabolomics services market
- Efficiently plan M&A and partnership deals in North America metabolomics services market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America metabolomics services market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Metabolomics Services Market Segmentation
North America Metabolomics Services Market –By Service Type
- Targeted Metabolomics Service
- Untargeted Metabolomics Service
North America Metabolomics Services Market –By Application
- Pharmaceutical and Biotechnology Industry
- Biomarker Discovery
- Drug Discovery
- Toxicological Testing
- Others
- Agritech
- Environment
North America Metabolomics Services Market -By Country
- US
- Canada
- Mexico
North America Metabolomics Services Market -Company Profiles
- BASF SE
- BGI
- biocrates life sciences ag
- Chenomx Inc.
- Creative Proteomics
- Fred Hutchinson Cancer Research Center
- Metabolon, Inc.
- Molecular You
- RTI International
- TMIC
- West Coast Metabolomics Center
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Metabolomics Services Market – By Service Type
1.3.2 North America Metabolomics Services Market – By Application
1.3.3 North America Metabolomics Services Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Metabolomics Services Market – Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Metabolomics Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidences of Cancer
5.1.2 Surge in Adoption of Metabolomics and Investments by Market Players
5.2 Market Restraints
5.2.1 High Price of Tools, Instruments, and Usage
5.3 Market Opportunities
5.3.1 Development Opportunities in Several Countries
5.4 Future Trends
5.4.1 Use of Artificial Intelligence (AI) and Biomarkers in Biomarker-Related Analysis and Personalized Therapy
5.5 Impact Analysis
6. Metabolomics Services Market– North America Analysis
6.1 North America Metabolomics Services Market Revenue Forecast and Analysis
7. North America Metabolomics Services Market Revenue and Forecasts to 2028– by Service Type
7.1 Overview
7.2 North America Metabolomics Services Market, By Service Type 2021 & 2028 (%)
7.3 Targeted Metabolomics Service
7.3.1 Overview
7.3.2 Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Untargeted Metabolomics Service
7.4.1 Overview
7.4.2 Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
8. North America Metabolomics Services Market Revenue and Forecasts to 2028 – by Application
8.1 Overview
8.2 North America Metabolomics Services Market Share by Application 2021 & 2028 (%)
8.3 Pharmaceutical and Biotechnology Industry
8.3.1 Overview
8.3.2 Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.1 Biomarker Discovery
8.3.2.1.1 Overview
8.3.2.1.2 Biomarker Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.2 Toxicological Testing
8.3.2.2.1 Overview
8.3.2.2.2 Toxicological Testing: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.3 Drug Discovery
8.3.2.3.1 Overview
8.3.2.3.2 Drug Discovery: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.3.2.4 Others
8.3.2.4.1 Overview
8.3.2.4.2 Others: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Agritech
8.4.1 Overview
8.4.2 Agritech: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Environment
8.5.1 Overview
8.5.2 Environment: Metabolomics Services Market Revenue and Forecast to 2028 (US$ Mn)
9. North America Metabolomics Services Market Revenue and Forecasts to 2028 – Country Analysis
9.1 Overview
9.1.1 North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
9.1.1.1 US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 US: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.1.1.3 US: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.1.1.3.1 US: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.1.1.2 Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Canada: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.1.2.3 Canada: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.1.2.3.1 Canada: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
9.1.1.3 Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 Mexico: Metabolomics Services Market, by Service Type, 2019–2028 (USD Million)
9.1.1.3.3 Mexico: Metabolomics Services Market, by Application, 2019–2028 (USD Million)
9.1.1.3.3.1 Mexico: Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Metabolomics Services Market
10.1 Overview
11. North America Metabolomics Services Market–Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 BASF SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 TMIC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Creative Proteomics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BGI
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 RTI International
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Fred Hutchinson Cancer Research Center
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 West Coast Metabolomics Center
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Molecular You
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Metabolon, Inc.
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 biocrates life sciences ag
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Chenomx Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Metabolomics Services Market Revenue and Forecast to 2028 (US$ Million)
Table 2. US Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. US Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Metabolomics Services Market, by Service Type – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Metabolomics Services Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Metabolomics Services Market, by Pharmaceutical and Biotechnology Industry – Revenue and Forecast to 2028 (USD Million)
Table 11. organic Developments Done By Companies
Table 12. Inorganic Developments Done By Companies
Table 13. Glossary of Terms, North America Metabolomics Services Market
LIST OF FIGURES
Figure 1. North America Metabolomics Services Market Segmentation
Figure 2. North America Metabolomics Services Market, By Country
Figure 3. North America Metabolomics Services Market Overview
Figure 4. Targeted Metabolomics Service Segment Held Largest Share of Type Segment in North America Metabolomics Services Market
Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis of Drivers and Restraints Pertaining to North America Metabolomics Services Market
Figure 9. North America Metabolomics Services Market– By Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Metabolomics Services Market, by Service Type 2021 & 2028 (%)
Figure 11. North America Targeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Untargeted Metabolomics Service: Metabolomics Services Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Metabolomics Services Market Share by Application 2021 & 2028 (%)
Figure 14. North America Pharmaceutical and Biotechnology Industry: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 15. North America Biomarker Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 16. North America Toxicological Testing: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 17. North America Drug Discovery: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 18. North America Others : Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. North America Agritech: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. North America Environment: Metabolomics Services Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. North America: Metabolomics Services Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. North America: Metabolomics Services Market, by Country, 2021 & 2028 (%)
Figure 23. US: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. Canada: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. Mexico: Metabolomics Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Impact of COVID-19 Pandemic in North American Country Markets
- BASF SE
- BGI
- biocrates life sciences ag
- Chenomx Inc.
- Creative Proteomics
- Fred Hutchinson Cancer Research Center
- Metabolon, Inc.
- Molecular You
- RTI International
- TMIC
- West Coast Metabolomics Center
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Metabolomics Services market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America Metabolomics Services market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Metabolomics Services market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution